daidzein supplementation decreases serum triglyceride and uric acid concentrations in hypercholesterolemic adults with the effect on triglycerides being greater in those with the GA compared with the GG genotype of ESR-β RsaI

Journal of Nutrition

Volumn 144, Issue 1, 2014, Pages 49-54

  Qin, Yu ^a   Shu, FuRong ^a   Zeng, Yuan ^a   Meng, XiangGui ^b   Wang, Bin ^a   Diao, LiPing ^b   Wang, Li ^a   Wan, Jing ^a   Zhu, JunDong ^a   Wang, Jian ^b   Mi, ManTian ^a  

^a Institute of Combined Injury   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DAIDZEIN; EQUOL; ESTROGEN RECEPTOR BETA; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; FEMALE; GENOTYPE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; NUTRIENT; RANDOMIZED CONTROLLED TRIAL; SMOKING; SUPPLEMENTATION; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

EID: 84890921999     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.113.182725     Document Type: Article

References (27)

1. Setchell KD, Clerici C. Equol: pharmacokinetics and biological actions. J Nutr. 2010;140:S1363-8.
2. Kreijkamp-Kaspers S, Kok L, Bots ML, Grobbee DE, Lampe JW, van der Schouw YT. Randomized controlled trial of the effects of soy protein containing isoflavones on vascular function in postmenopausal women. Am J Clin Nutr. 2005;81:189-95.
3. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equola clue to the effectiveness of soy and its isoflavones. J Nutr. 2002;132:3577-84.
4. Wong JM, Kendall CW, Marchie A, Liu Z, Vidgen E, Holmes C, Jackson CJ, Josse RG, Pencharz PB, Rao AV, et al. Equol status and blood lipid profile in hyperlipidemia after consumption of diets containing soy foods. Am J Clin Nutr. 2012;95:564-71.
5. Wu J, Oka J, Ezaki J, Ohtomo T, Ueno T, Uchiyama S, Toda T, Uehara M, Ishimi Y. Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a doubleblind, randomized, controlled trial. Menopause. 2007;14:866-74.
6. Marini H, Bitto A, Altavilla D, Burnett BP, Polito F, Di Stefano V, Minutoli L, Atteritano M, Levy RM, Frisina N, et al. Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: a followup study. Nutr Metab Cardiovasc Dis. 2010;20:332-40.
7. Ricci E, Cipriani S, Chiaffarino F, Malvezzi M, Parazzini F. Effects of soy isoflavones and genistein on glucose metabolism in perimenopausal and postmenopausal non-Asian women: a metaanalysis of randomized controlled trials. Menopause. 2010;17:1080-6.
8. D'Anna R, Cannata ML, Marini H, Atteritano M, Cancellieri F, Corrado F, Triolo O, Rizzo P, Russo S, Gaudio A, et al. Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 2-year randomized, double- blind, placebocontrolled study. Menopause. 2009;16:301-6.
9. Atteritano M, Mazzaferro S, Frisina A, Cannata ML, Bitto A, D'Anna R, Squadrito F, Macri I, Frisina N, Buemi M. Genistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women. Osteoporos Int. 2009;20:1947-54.
10. Khaodhiar L, Ricciotti HA, Li LL, Pan WJ, Sehickel M, Zhou JR, Blackburn GL. Daidzeinrich isoflavone aglycones are potentially effective in reducing hot flashes in menopausal women. Menopause. 2008;15:125-32.
11. Taku K, Umegaki K, Sato Y, Taki Y, Endoh K, Watanabe S. Soy isoflavones lower serum total and LDL cholesterol in humans: a metaanalysis of 11 randomized controlled trials. Am J Clin Nutr. 2007;85:1148-56.
12. Zhan S, Ho SC. Metaanalysis of the effects of soy protein containing isoflavones on the lipid profile. Am J Clin Nutr. 2005;81:397-408.
13. Taku K, Umegaki K, Ishimi Y, Watanabe S. Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: Metaanalysis of randomized controlled trials. Ther Clin Risk Manag. 2008;4:1097-103.
14. Hall WL, Vafeiadou K, Hallund J, Bugel S, Reimann M, Koebnick C, Zunft HJ, Ferrari M, Branca F, Dadd T, et al. Soyisoflavoneenriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production. Am J Clin Nutr. 2006;83:592-600.
15. Hall WL, Vafeiadou K, Hallund J, Bugel S, Koebnick C, Reimann M, Ferrari M, Branca F, Talbot D, Dadd T, et al. Soyisoflavoneenriched foods and inflammatory biomarkers of cardiovascular disease risk in postmenopausal women: interactions with genotype and equol produc- tion. Am J Clin Nutr. 2005;82:1260-8.
16. Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008;359:1811-21.
17. Alderman M, Aiyer KJ. Uric acid: role in cardiovascular disease and effects of losartan. Curr Med Res Opin. 2004;20:369-79.
18. Guo K, Zhang B, Chen C, Uchiyama S, Ueno T, Chen Y, Su Y. Daidzein- metabolising phenotypes in relation to serum lipids and uric acid in adults in Guangzhou, China. Br J Nutr. 2010;104:118-24.
19. Liu B, Qin L, Liu A, Uchiyama S, Ueno T, Li X, Wang P. Prevalence of the equolproducer phenotype and its relationship with dietary isoflavone and serum lipids in healthy Chinese adults. J Epidemiol. 2010;20:377-84.
20. Setchell KD, Cole SJ. Method of defining equolproducer status and its frequency among vegetarians. J Nutr. 2006;136:2188-93.
21. Qin Y, Xia M, Ma J, Hao Y, Liu J, Mou H, Cao L, Ling W. Anthocyanin supplementation improves serum LDL- and HDL-cholesterol concen- trations associated with the inhibition of cholesteryl ester transfer protein in dyslipidemic subjects. Am J Clin Nutr. 2009;90:485-92.
22. Saltiki K, Mantzou E, Doukas C, Kanakakis I, Zotos P, Lazaros L, Georgiou I, Alevizaki M. Estrogen receptor beta gene variants may be associated with more favorable metabolic profile in postmenopausal women undergoing coronary angiography. Exp Clin Endocrinol Dia- betes. 2009;117:610-5.
23. Sakka C, Efstathiadou ZA, Polyzos SA, Goutou M, Stakias N, Koukoulis GN. Associations of estrogen receptor alpha and beta gene polymorphisms with sex steroid levels and body fat content in men. Exp Clin Endocrinol Diabetes. 2012;120:154-9.
24. Liu ZM, Ho SC, Chen YM, Ho YP. The effects of isoflavones combined with soy protein on lipid profiles, C-reactive protein and cardiovascular risk among postmenopausal Chinese women. Nutr Metab Cardiovasc Dis. 2012;22:712-9.
25. Chen CY, Bakhiet RM, Hart V, Holtzman G. Isoflavones improve plasma homocysteine status and antioxidant defense system in healthy young men at rest but do not ameliorate oxidative stress induced by 80% VO2pk exercise. Ann Nutr Metab. 2005;49:33-41.
26. Khan N, Sultana S. Abrogation of potassium bromateinduced renal oxidative stress and subsequent cell proliferation response by soy isoflavones in Wistar rats. Toxicology. 2004;201:173-84.
27. Franke AA, Lai JF, Halm BM, Pagano I, Kono N, Mack WJ, Hodis HN. Equol production changes over time in postmenopausal women. J Nutr Biochem. 2012;23:573-9.